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Abstract Prodigiosin 25-C inhibited the accumulation of 3-(2,4- 
dinitroanilino)-3'-amino-N-methyidipropylamine and acridine or- 
ange in the acidic compartments of baby hamster kidney cells 
with little perturbation of cellular ATP levels. In rat liver lyso- 
somes, prodiginsin 25-C inhibited the proton pump activity with 
an IC5o of approximately 30 nM, but did not affect ATPase 
activity up to 1 ttM. It also delayed the transport of vesicular 
stomatitis virus G protein and induced a drastic swelling of Golgi 
apparatus and mitochondria. These results indicate that prodigi- 
osin 25-C raises the pH of acidic compartments hrough inhibition 
of the proton pump activity of vacuolar type H+-ATPase, thereby 
causing the functional and morphological changes to the Golgi 
apparatus. 
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lar level has yet to be determined, although it is known to 
inhibit the mitogen response of murine splenocytes and growth 
of T cell lymphoma more strongly at a higher concentration of
Con A [16,19]. Among a panel of inhibitors we tested, acidic 
monovalent ionophores (e.g. monensin and nigericin), V-ATP- 
ase inhibitors (e.g. bafilomycin B~ and concanamycin A), and 
Golgi mannosidase II inhibitor (swainsonine), were also more 
cytotoxic to those cells after addition of Con A [20]. These 
reagents, except for swainsonine, raise the pH in the acidic 
compartments and affect intracellular t ansport of glycoprotein 
[9,10,21-23]. In this paper, we have studied the effect of prodig- 
iosin 25-C on vacuolar acidification, intracellular t ansport of 
glycoprotein, and morphology of BHK cells, and we have 
found that prodigiosin 25-C uncouples V-ATPase and raises 
the pH of vacuolar organelles in intact cells. 
I. Introduction 
Vacuolar organelles of eukaryotic cells such as Golgi appara- 
tus, endosomes, lysosomes, and secretory vesicles, are acidified 
by the proton pump activity of vacuolar type H÷-ATPase 
(V-ATPase), and their internal acidification plays an essential 
role in endocytic and exocytic pathways [1]. V-ATPases have 
been identified and purified from a variety of organelles of 
eukaryotic ells and are clearly distinguished from other H ÷- 
ATPases by the inhibitor specificity [1,2]. Recently, bafilomy- 
cins [3] and concanamycins [4], originally found in microbial 
metabolites, have been shown to be specific inhibitors of V- 
ATPase and have become the most useful probes to study 
vacuolar acidification by V-ATPase [5-11]. 
Prodigiosin 25-C is one of the red pigments produced by 
microorganisms including Streptomyces and Serratia [12,13]. 
We found that prodigiosin 25-C isolated from the culture broth 
of Streptomyces hiroshimensis [14] acts as a selective inhibitor 
of T cell proliferation i duced by concanavalin A (Con A) and 
exerts immunomodulating activities in immunized mice [ 15-18]. 
However, the molecular target of prodigiosin 25-C at the cellu- 
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Abbreviations: BHK, baby hamster kidney; Con A, concanavalin A;
DAMP, 3-(2,4-dinitroanilino)-3'-amino-N-methyldipropylamine; FITC, 
fluorescein isothiocyanate; G, glycoprotein; mAb, monoclonal anti- 
body; TMG, Triton-filled lysosomes; V-ATPase, vacuolar type 
H+-ATPase; VSV, vesicular stomatitis virus. 
2. Experimental 
2.1. Materials 
Baby hamster kidney (BHK) cells were maintained in Eagle's mini- 
mal essential medium (Gibco Laboratories, Gland Island, NY) supple- 
mented with 10% (v/v) fetal calf serum (Bioserum, Victoria, Australia) 
and 50/ag/ml kanamycin. Rats (Wistar, male) were obtained from 
Sankyo Labo Service (Tokyo, Japan). Prodigiosin 25-C (molecular 
weight 393) was prepared from the culture broth of Streptomyces 
hiroshimensis a described previously [14]. Bafilomycin A~ and concana- 
mycin A were kindly provided by Prof. K. Altendorf, University of 
Osnabriick (Osnabriick, Germany) and Dr. K. Mizoue, Taisho Phar- 
maceutical Co. (Tokyo, Japan), respectively. Other reagents were pur- 
chased as commercial products. 
2.2. Visualization of vacuolar acidification 
3-(2,4-Dinitroanilino)-3'-amino-N-methyldipropylamine (DAMP) 
and acridine orange were used for the visualization of vacuolar acidifi- 
cation. DAMP stain was basically performed according to the methods 
described previously [24]. Briefly, BHK cells on coverslips were treated 
with prodigiosin 25-C for 30 min and further incubated with 30 pM 
DAMP (Oxford Biomedical Research Inc., Oxford, MI) for 30 min. 
Then the cells were fixed with paraformaldehyde, th n incubated with 
anti-dinitrophenol monoclonal antibody (mAb) (Oxford Biomedical 
Research) and reacted with phycoerythrin-conjugated anti-mouse IgG 
mAb (Tago Inc., Burlingame, CA). For acridine orange stain, BHK 
cells on coverslips were treated with prodigiosin 25-C for 30 min and 
further incubated with 5/tg/ml of acridine orange (Polyscience Inc., 
Warrington, PA) for 30 min. 
2.3. Measurement ofcellular ATP content 
Immediately after emoval of culture medium, BHK cells were frozen 
on dry ice, suspended in 1 ml of water and sonicated for 30 s in a water 
bath. 100pl of the samples were used for measuring ATP content using 
lucifer-LU plus kit (Kikkoman, Chiba, Japan). 
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2.5. Proton pump assay 
Preparation of fluorescein isothiocyanate (FITC)-dextran loaded ly- 
sosomes (dextranosomes) from rat liver and proton pump assay (acid- 
ification) were performed according to the methods described previ- 
ously [27-29]. 
2.6. Labeling of VSV G protein 
Preparation of VSV (New Jersey serotype) and labeling of VSV G 
protein were basically performed according to the methods described 
previously [9]. After BHK cells were absorbed with VSV (MOI 10) for 
t3 
2. 7. Transmission electron microscopy 
BHK cells removed from culture dishes using trypsin were prefixed 
with glutaraldehyde, postfixed with osmium tetroxide and embedded 
in Epon 812 after dehydration i  a series of ethanol concentrations. 
2.4. A TPase assay 
Preparation of membrane ghosts from Triton-filled lysosomes 
(TMG) of rat liver, solubilization of TMG, and ATPase assay were 
essentially based on the methods described previously [25,26]. 
2.5 h in a microtiter plate, the medium was replaced with methionine 
deficient medium. BHK cells were incubated for 1.5 h in the presence 
or absence of prodigiosin 25-C. The culture medium contained the 
designated concentrations of prodigiosin 25-C throughout the experi- 
ment. 35S protein labeling mixture (370 kBq/ml; NEN Research Prod- 
uct, Boston, MA) was added to the culture, and the cells were labeled 
for 2 h and chased for 2 h in the presence of unlabeled methionine 
(150 gg/ml) and cycloheximide (1/tg/ml). The culture supernatant was 
centrifuged at 150 × g for 5 min and the resultant precipitates and the 
cells were combined (the cell fraction). 
N 
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Fig. 1. Visualization of vacuolar acidification i  BHK cells. (A-D) BHK cells were incubated in the absence (A) or presence (B, 25 nM; C, 250 nM; 
and D, 2.5 gM) of prodigiosin 25-C for 30 rain, and further incubated with DAMP for 30 min. DAMP was visualized by the method escribed in 
section 2. The cells were observed under fluorescent microscopy. (E and F) BHK cells were incubated in the presence of prodigiosin 25-C alone (E, 
2.5 gM; and F, 25 gM) for 1 h, and the autofluorescence of prodigiosin 25-C was viewed under fluorescent microscopy. (G and H) BHK cells were 
incubated in the absence (G) or presence of 250 nM prodigiosin 25-C (H) for 30 min, and further incubated with acridine orange for 30 min. The 
cells were observed under fluorescent microscopy. 
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Fig. 1. (continued). 
Ultrathin sections were stained with uranyl acetate and lead citrate, and 
observed under 1200EX transmission electron microscopy (JEOL, 
Tokyo, Japan). 
3. Results 
In order to visualize vacuolar acidification, DAMP was used 
as a pH probe (Fig. 1A-1D). Yellow granules were frequently 
observed in the cytoplasm of control BHK cells, showing acid- 
ification of vacuolar organelles (Fig. 1A). On the other hand, 
they were significantly decreased in cells treated with prodigi- 
osin 25-C at 250 nM (Fig. 1C) and disappeared almost com- 
pletely at 2.5 pM (Fig. 1D), suggesting an increase in vacuolar 
pH. Granular green fluorescence could also be seen in BHK 
cells treated with 2.5/.tM prodigiosin 25-C (Fig. 1D), which is 
most probably due to autofluorescence of prodigiosin 25-C 
because BHK cells treated with prodigiosin 25-C alone showed 
similar green fluorescent areas at 2.5/IM (Fig. 1E) and 25 pM 
(Fig. IF). Interestingly, prodigiosin 25-C appears to be selec- 
tively localized in cytoplasmic granules and accumulated on 
one side of the cytoplasm near the nucleus but not inside the 
nucleus or by the plasma membrane (Fig. 1F). 
To have additional support for the pH increase produced by 
prodigiosin 25-C in intact cells, acridine orange stain was per- 
formed. Granular orange dots were observed in the green back- 
ground in control BHK cells (Fig. 1G), whereas they were 
significantly smaller and decreased in number in cells treated 
with 250 nM prodigiosin 25-C (Fig. 1H). These results clearly 
demonstrate hat prodigiosin 25-C raises the pH in acidic com- 
partments of intact ceils. 
To see if this effect of prodigiosin 25-C is a consequence of
its general degenerative effect, cellular ATP content was esti- 
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mated in cells treated with the drug (Table 1). Like other pH 
perturbing agents, prodigiosin 25-C had no inhibitory effect on 
the cellular ATP level at 250 nM and decreased it by only 10% 
at 2.5/tM. In contrast, oligomycin, an inhibitor of mitochon- 
drial F-type ATPase, decreased the ATP level by approximately 
50%. This result indicates that prodigiosin 25-C does not signif- 
icantly affect cellular ATP production. 
Prodigiosin 25-C is a lipophilic weak base [12], however, it 
hardly affected the internal pH (~ 5.7) oflysosomes i olated from 
rat liver in neutral buffer at the low concentrations (up to 1 pM) 
used in this study (data not shown). The internal pH of acidic 
organelles i maintained by the activity of V-ATPase. Accord- 
ingly, we next examined the effect of prodigiosin 25-C on the 
proton pump (Fig. 2A) and ATPase (Fig. 2B) activities of 
V-ATPase in isolated lysosomes from rat liver. Prodigiosin 
25-C inhibited the proton pump activity (acidification) with an 
IC50 of approximately 30 nM (Fig. 2A). However, it hardly 
affected the ATPase activity up to 1/IM (Fig. 2B). In contrast, 
bafilomycin A~ inhibited both proton pump and ATPase activ- 
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Fig. 2, Proton pump and ATPase activities in rat liver lysosomes. 
(A) FITC~lextran containing lysosomes were incubated with prodigi- 
osin 25-C (e) or bafilomycin AI (o), and fluorescence quenching was 
measured after the addition of ATP. The plots were the average of 
duplicate samples. (B) V-ATPase activity in solubilized TMG was 
measured by the release of inorganic phosphate from ATP. The reac- 
tion mixture was incubated with prodigiosin 25-C (o) or bafilomycin 
A, (o). The plots are the average of duplicate samples. 
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Fig. 3. Intracellular t ansport of VSV G protein. VSV-infected BHK 
cells were incubated at 37°C with prodigiosin 25-C (lanes 1 and 6, 0; 
anes 2 and 7, 2.5 nM; lanes 3 and 8, 125 nM; lanes 4 and 9, 250 nM; 
lanes 5 and 10, 2.5/~M;). The labeled proteins in the cell fraction (lanes 
1-5) and the medium fraction (lanes 6-10) were separated by 10% 
SDS-PAGE and autoradiographed. L, large protein; G, glycoprotein; 
N, nucleocapsid protein; NS, non-structural protein; M, matrix protein. 
ities strongly at the same concentration. Prodigiosin 25-C also 
inhibited the proton pump activity of lysosomal H÷-ATPase 
(IC50 ~ a few nM) in the reconstituted proteoliposomes which 
are free from anion channels (data not shown; S. Ohkuma et 
al., manuscript in preparation). These results suggest that 
prodigiosin 25-C inhibits the proton pump activity of V-ATP- 
ase by dissociating proton translocation from ATP hydro- 
lysis. 
VSV is a useful tool to study the intracellular t ansport of 
glycoproteins, ince cellular macromolecular synthesis is shut 
off after the infection of VSV and only viral proteins, including 
Table 1 
Cellular ATP level in BHK cells 
Treatments Concentration Cellular ATP (% of control) 
(tiM) (pmol/103 cells) 
Control 5.59 (100.0) 
Prodigiosin 25-C 0.25 5.61 (100.4) 
2.5 5.06 (90.5) 
Concanamycin A 1.0 5.80 (103.8) 
Monensin 1.0 5.50 (98.4) 
Oligomycin 0.1 2.77 (49.6) 
BHK cells were treated with various inhibitors for 1 h and the cellular 
ATP content was measured. The data shown are averages of duplicate 
samples. 
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Fig. 4. Transmission electron micrographs ofBHK cells. BHK cells were incubated inthe absence (A and B) or presence of 250 nM prodigiosin 25-C 
(C and D) for 1 h. Panels B and D are magnified pictures of A and C, respectively. 
G protein (glycoprotein), are synthesized. Fig. 3 shows the dose 
dependence of the effect of prodigiosin 25-C on the transport 
of VSV G protein. In control cells, G protein was secreted into 
the medium (lane 6) after 2 h chase in the presence of unlabeled 
methionine and cycloheximide, and only broad and faint bands 
were detected in the cell fraction (lane 1). In contrast, when cells 
were treated with prodigiosin 25-C at concentrations of 250 nM 
(lane 4) and 2.5/~M (lane 5), considerable amounts of G protein 
were clearly retained in the cell fraction. Under these condi- 
tions, G protein was also detected in the medium but its molec- 
ular weight was slightly decreased (lanes 9 and 10). Other pro- 
teins, such as L, N, NS and M, were not significantly influenced 
by prodigiosin 25-C. These results indicate that prodigiosin 
25-C slows down the transport of G protein without decreasing 
protein synthesis. 
We also observed the morphological changes in BHK cells 
treated with prodigiosin 25-C under transmission electron mi- 
croscopy (Fig. 4). Golgi apparatus and mitochondria were 
clearly observed in control BHK cells (Fig. 4B), while Golgi 
apparatus were significantly dilated and mitochondria swollen 
in cells that were treated with 250 nM prodigiosin 25-C for 
1 h (Fig. 4D). Prodigiosin 25-C did not induce any other signifi- 
cant changes in the endoplasmic reticulum or nucleus under 
these conditions. 
4. Discussion 
In this paper, we have shown that prodigiosin 25-C raises the 
internal pH of acidic organelles in intact cells through inhibi- 
tion of the proton pump activity of V-ATPase, thereby causing 
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the functional and morphological changes to Golgi apparatus. 
Prodigiosin 25-C inhibited the proton pump activity but not the 
ATP hydrolysis activity. This is consistent with our previous 
results on the plant V-ATPase showing inefficient inhibition of 
its ATPase activity by prodigiosin 25-C [20]. As anion channels 
do not seem to participate in the inhibition of acidification by 
prodigiosin 25-C, it is suggested that prodigiosin 25-C inhibits 
acidification (and increases vacuolar pH) by dissociating (or 
uncoupling) proton translocation from ATP hydrolysis on 
V-ATPase. Furthermore, prodigiosin 25-C does not show sig- 
nificant protonophore (S. Ohkuma, unpublished observation) 
or potassium ionophore [20] activities at the concentrations 
used, unlike general 'uncouplers of oxidative phosphorylation'. 
These observations indicate that prodigiosin 25-C may be a new 
type of inhibitor of H+-ATPase with potential usefulness for the 
clarification of the proton translocation mechanism. 
Probably as a consequence ofincreased vacuolar pH, prodig- 
iosin 25-C delayed the transport of VSV G protein while 
slightly decreasing its molecular weight. Monensin blocks or 
slows down the intracellular transport of glycoprotein [21-23] 
and arrests the transport of VSV G protein prior to reaching 
the trans Golgi compartment. Bafilomycin A1 and concanamy- 
cin A also effectively block the cell surface expression of VSV 
G protein [9,10] but concanamycin A stops the transport of G 
protein from the endoplasmic reticulum to the cis Golgi com- 
partment [9]. Compared with these inhibitors, the action of 
prodigiosin 25-C on the transport of VSV G protein appears 
to be quite leaky. Moreover, prodigiosin 25-C up to 250 nM 
did not neutralize the toxicity of diphtheria toxin, but partially 
neutralized it at 2.5 gM in our system (data not shown), while 
bafilomycin Al neutralizes the toxicity of diphtheria toxin 
strongly [6]. These observations suggest that prodigiosin 25-C 
does not increase the pH of acidic compartments to the same 
level as the other inhibitors in intact cells. 
The decrease in the molecular weight of G protein by prodig- 
iosin 25-C might be due to a defect in the addition of terminal 
sugars such as sialic acids, because the decrease in the content 
of sialic acids on glycoproteins has been reported in acidifica- 
tion defective cells [30] and in cystic fibrosis which is defective 
of the chloride channel [31]. The internal pH of the trans Golgi/ 
trans Golgi network in cystic fibrosis is slightly raised in a range 
from pH 6.5 to 6.8 [31], since vacuolar acidification is depend- 
ent on chloride channels [32]. This pH increase is thought o 
reduce the activity of sialyltransferase which has an acidic pH 
optima and the content of sialic acids is decreased. A similar 
mechanism appears to occur in prodigiosin 25-C treated cells. 
Prodigiosin 25-C induced significant dilation of Golgi appa- 
ratus. Monensin also induces a drastic dilation of Golgi appa- 
ratus, possibly due to the passive influx of water caused by ionic 
imbalance [22,23]. Although it is likely that the inhibition of the 
proton pump activity of V-ATPase by prodigiosin 25-C may 
trigger the ionic and/or osmotic imbalances, thereby resulting 
in the water influx, the precise mechanism leading to the dila- 
tion of Golgi remains to be clarified. 
Although the morphological effects on Golgi apparatus are 
similar between prodigiosin 25-C and monensin, those on mito- 
chondria re quite different from each other; prodigiosin 25-C 
also induced the swelling of mitochondria (Fig. 4), while 
monensin induces the contraction of mitochondria [22,23]. We 
have found that prodigiosin 25-C also inhibited the proton 
pump activity of mitochondrial ATPase (S. Ohkuma, unpub- 
lished observation). However, prodigiosin 25-C did not de- 
crease cellular ATP levels (Table 1) and viral protein synthesis 
in BHK cells at 2.5 gM, similar to monensin [23]. The swelling 
might be due to the accelerated uptake of potassium ions by 
energized mitochondria which retain active electron transport 
in the presence of prodigiosin 25-C, but further studies are 
required. 
Prodigiosin 25-C accumulated in the cytoplasmic granules, 
as judged by its autofluorescence under microscopic observa- 
tion. Since prodigiosin 25-C has an apparent pKa value of 7.62 
[12], the drug appears to accumulate selectively as a weak base 
in acidic compartments, although a more specific mechanism 
might also participate in its perinuclear accumulation. On the 
other hand, the matrix of mitochondria in which F-ATPase is 
localized has a more alkaline pH than the cytosol when the 
electron transport system is active. Therefore, prodigiosin 25-C 
may accumulate inefficiently in the mitochondria and be unable 
to effectively inhibit the proton translocation of mitochondrial 
ATPase in live cells, and hence have little influence on cellular 
ATP levels. 
Further studies are now in progress to clarify fully the mech- 
anism of action of prodigiosin 25-C on H+-ATPases. 
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